Anti-Human C5 Recombinant Antibody(Ravulizumab)

Name: Anti-Human C5 Recombinant Antibody(Ravulizumab)
Brand: KMD Bioscience
SKU: YR1443

YR1443

科研级 Ravulizumab ( 雷夫利珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Ravulizumab

DATASHEET MSDS

Product Description

Alias	科研级 Ravulizumab ( 雷夫利珠单抗 ), Anti-C5 Recombinant Antibody, Research Grade Ravulizumab
Catalog Number	YR1443
Molecular Name	Ravulizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2-G4 Kappa
Formulation	PBS, pH7.5
Background	Ravulizumab, sold under the brand name Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5).
CAS Number	1803171-55-2
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	C5[Homo sapiens]

Login